Form 4: Select Medical Holdings Corp. Executive Sells Shares in Merger

Select Medical Holdings Corp. Senior Vice President Christopher Weigl reports transactions related to the company's merger, including share exchanges and cash conversion.

Summary

• Christopher Weigl, Senior Vice President of Select Medical Holdings Corp., has reported transactions related to the company's merger.
• On June 30, 2026, 40,000 restricted shares were contributed to Parent in exchange for equivalent restricted shares of Parent, which were then exchanged for interests in Stallion Group Parent, LP.
• Additionally, 12,382 shares of common stock were converted into the right to receive $16.50 per share in cash without interest at the effective time of the merger.
• 1,872 shares were surrendered to satisfy tax withholding obligations related to restricted stock vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports on transactions that have already occurred due to a merger and does not contain new financial performance data or forward-looking statements.

Future Outlook

The filing details transactions that have occurred as a result of a merger agreement, indicating the completion of a significant corporate event. No future guidance is provided in this specific filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, particularly relevant during significant corporate events like mergers. This filing provides transparency regarding executive participation in the Select Medical Holdings Corp. merger.

Stakeholder Impact

• Shareholders: The merger transaction, as detailed by executive share conversions, directly impacts the value and form of shareholder holdings.

Key Dates

Keywords

SEC Form 4, Select Medical Holdings Corp, SEM, Merger, Insider Trading, Shareholder, Executive Compensation, Stock Transaction